FDA grants quick review for 3 psychedelic drug trials

  • Now Playing

    FDA grants quick review for 3 psychedelic drug trials

    02:00

  • UP NEXT

    Trump signs order to speed up review of psychedelic drugs for mental health treatment

    03:14

  • Google sued over Gemini’s alleged role in man’s suicide

    04:55

  • Plaintiff’s testimony delayed a day in landmark social media addiction trial

    04:10

  • Lawsuit alleges insurance company provider list is a “Ghost Network”

    03:31

  • Landmark court case puts big tech companies on trial

    03:26

  • Toms Shoes founder unveils new project highlighting mental health

    03:53

  • American Psychology Association warns against using AI for therapy

    05:05

  • How the 1-1-1 Journaling Method Can Help You Reflect Effectively

    03:28

  • College students learning to identify and support mental health struggles

    05:49

  • Teen volunteers run hotline for youth in crisis

    03:00

  • Ohio mother faces murder charges after husband and son drown

    02:30

  • Victims identified in Austin parking lot shooting

    03:04

  • ChatGPT implements new mental health guardrails

    01:54

  • Kevin Love Sits Down With Hoda Kotb on ‘Making Space’

    01:24

  • Washington deputy uses lasso to detain chainsaw-wielding man

    00:47

  • How to Master the Art of Agreeing to Disagree in a Relationship

    04:28

  • Study shows higher than average depression and suicide rates for Asian American youth

    04:12

  • Gen Z entrepreneurs trade corporate life for meaningful work

    02:38

  • Foundation aims to improve access to mental health services for young people

    04:51

NBC News NOW

The Food and Drug Administration granted a quick review of three experimental psychedelic drugs meant to treat major depression and post-traumatic stress disorder. NBC News’ Erika Edwards reports on the specific drugs under review and how the FDA determines whether they are safe and effective.


Source: Read Full Article

Sam Miller

Leave a Reply

Your email address will not be published. Required fields are marked *